See also:

Website

23andMe

Get involved in a new way of doing research.

23andMe, a personal genetics company, is dedicated to accelerating the pace of research and making discoveries that lead to improved patient care. By combining participants' genetic data with survey responses about their health and experiences, we hope to discover new genetic markers for diseases, understand why some people respond to treatment more readily than others, and explore gene-environment interactions.

23andMe's innovative research model enables individuals to take an active role in research and their own healthcare. 23andMe has ongoing research projects in several disease areas, such as Sarcoma, Myeloproliferative Neoplasms, and Parkinson’s Disease. The Roots into the Future initiative involves recruiting 10,000 African Americans into a study to explore connections between DNA and disease in diverse ethnic groups.

23andMe believes in empowering individuals with their own genetic information, and helps individuals understand this information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service® enables people to gain deeper insights into their ancestry and inherited traits.

Contact information:

Programs

Developments in Myelofibrosis: Ongoing Trials and the Significance of Mutations

Dr. Ruben Mesa of the Mayo Clinic, shares his optimism for patients living with myeloproliferative disorders, particularly Myelofibrosis.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on November 6, 2013